You obviously did not read the entire document. The Melblez Kit is treatment for an unmet need that elicits statistically significant changes in the progression of hepatic cancer. This is going to be a no-brainer recommendation for approval by the FDA panel. The brief notes clearly indicate that the product is capable of providing a treatment for an unmet need. Friday should be a great recovery day for DCTH pps.